Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 25061876)

1.

Proteasome function is required for platelet production.

Shi DS, Smith MC, Campbell RA, Zimmerman PW, Franks ZB, Kraemer BF, Machlus KR, Ling J, Kamba P, Schwertz H, Rowley JW, Miles RR, Liu ZJ, Sola-Visner M, Italiano JE Jr, Christensen H, Kahr WH, Li DY, Weyrich AS.

J Clin Invest. 2014 Sep;124(9):3757-66. doi: 10.1172/JCI75247. Epub 2014 Jul 25.

2.

Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.

Murai K, Kowata S, Shimoyama T, Yashima-Abo A, Fujishima Y, Ito S, Ishida Y.

Eur J Haematol. 2014 Oct;93(4):290-6. doi: 10.1111/ejh.12342. Epub 2014 May 16.

PMID:
24750292
3.

RhoA is essential for maintaining normal megakaryocyte ploidy and platelet generation.

Suzuki A, Shin JW, Wang Y, Min SH, Poncz M, Choi JK, Discher DE, Carpenter CL, Lian L, Zhao L, Wang Y, Abrams CS.

PLoS One. 2013 Jul 23;8(7):e69315. doi: 10.1371/journal.pone.0069315. Print 2013.

4.

Proplatelet generation in the mouse requires PKCε-dependent RhoA inhibition.

Gobbi G, Mirandola P, Carubbi C, Masselli E, Sykes SM, Ferraro F, Nouvenne A, Thon JN, Italiano JE Jr, Vitale M.

Blood. 2013 Aug 15;122(7):1305-11. doi: 10.1182/blood-2013-04-490599. Epub 2013 Jul 9.

6.

The role of platelet factor 4 in radiation-induced thrombocytopenia.

Lambert MP, Xiao L, Nguyen Y, Kowalska MA, Poncz M.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1533-40. doi: 10.1016/j.ijrobp.2011.03.039.

7.

Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.

Mazharian A, Watson SP, Séverin S.

Exp Hematol. 2009 Oct;37(10):1238-1249.e5. doi: 10.1016/j.exphem.2009.07.006. Epub 2009 Jul 18.

8.

Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation.

Machlus KR, Thon JN, Italiano JE Jr.

Br J Haematol. 2014 Apr;165(2):227-36. doi: 10.1111/bjh.12758. Epub 2014 Feb 6. Review.

PMID:
24499183
9.

Proteasome proteolysis supports stimulated platelet function and thrombosis.

Gupta N, Li W, Willard B, Silverstein RL, McIntyre TM.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):160-8. doi: 10.1161/ATVBAHA.113.302116. Epub 2013 Oct 31.

10.

Terminal platelet production is regulated by von Willebrand factor.

Poirault-Chassac S, Nguyen KA, Pietrzyk A, Casari C, Veyradier A, Denis CV, Baruch D.

PLoS One. 2013 May 30;8(5):e63810. doi: 10.1371/journal.pone.0063810. Print 2013.

11.

Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3.

Larson MK, Watson SP.

Blood. 2006 Sep 1;108(5):1509-14. Epub 2006 May 2.

12.

Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42.

Pleines I, Dütting S, Cherpokova D, Eckly A, Meyer I, Morowski M, Krohne G, Schulze H, Gachet C, Debili N, Brakebusch C, Nieswandt B.

Blood. 2013 Oct 31;122(18):3178-87. doi: 10.1182/blood-2013-03-487942. Epub 2013 Jul 16.

13.

Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.

Mazharian A, Mori J, Wang YJ, Heising S, Neel BG, Watson SP, Senis YA.

Blood. 2013 May 16;121(20):4205-20. doi: 10.1182/blood-2012-08-449272. Epub 2013 Mar 18.

14.

Dasatinib enhances megakaryocyte differentiation but inhibits platelet formation.

Mazharian A, Ghevaert C, Zhang L, Massberg S, Watson SP.

Blood. 2011 May 12;117(19):5198-206. doi: 10.1182/blood-2010-12-326850. Epub 2011 Mar 8.

15.

Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.

Lev PR, Grodzielski M, Goette NP, Glembotsky AC, Espasandin YR, Pierdominici MS, Contrufo G, Montero VS, Ferrari L, Molinas FC, Heller PG, Marta RF.

Br J Haematol. 2014 Jun;165(6):854-64. doi: 10.1111/bjh.12832. Epub 2014 Mar 27.

PMID:
24673454
16.

Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.

Bender M, Giannini S, Grozovsky R, Jönsson T, Christensen H, Pluthero FG, Ko A, Mullally A, Kahr WH, Hoffmeister KM, Falet H.

Blood. 2015 Feb 5;125(6):1014-24. doi: 10.1182/blood-2014-07-587857. Epub 2014 Dec 2.

PMID:
25468568
17.

Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout.

Hitchcock IS, Fox NE, Prévost N, Sear K, Shattil SJ, Kaushansky K.

Blood. 2008 Jan 15;111(2):596-604. Epub 2007 Oct 9.

18.
19.

The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway.

Chen Z, Naveiras O, Balduini A, Mammoto A, Conti MA, Adelstein RS, Ingber D, Daley GQ, Shivdasani RA.

Blood. 2007 Jul 1;110(1):171-9. Epub 2007 Mar 28.

20.

PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice.

Williams CM, Harper MT, Poole AW.

Platelets. 2014;25(1):62-8. doi: 10.3109/09537104.2012.761686. Epub 2013 Feb 12.

PMID:
23402219
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk